|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
24 Apr 2023, 22:35
Kudos
Bookmarks
(A) Many drugs undergoing clinical trials are intended for the treatment of conditions for which there is currently no effective treatment. This answer choice does not cast doubt on the conclusion of the argument. It does not address the argument's claim that physicians have a moral obligation to encourage suitable patients to volunteer for clinical trials.
(B) Patients do not share the physician’s professional concern for public health, but everyone has a moral obligation to alleviate suffering when able to do so. This answer choice does not address the argument's claim that physicians have a moral obligation to encourage suitable patients to volunteer for clinical trials. Furthermore, it is not clear how this claim is relevant to the argument.
(C) Usually, half the patients in a clinical trial serve as a control group and receive a nonactive drug in place of the drug being tested. This answer choice does not cast doubt on the conclusion of the argument. It does not address the argument's claim that physicians have a moral obligation to encourage suitable patients to volunteer for clinical trials.
(D) An experimental drug cannot legally be made available to patients unless those patients are subjects in clinical trials of the drug. This answer choice does not cast doubt on the conclusion of the argument. It supports the argument's claim that clinical trials are necessary before drugs can be made available to patients, but it does not address the argument's claim that physicians have a moral obligation to encourage suitable patients to volunteer for clinical trials.
(E) Physicians have an overriding moral and legal duty to care for the health and safety of their current patients. This answer choice casts doubt on the conclusion of the argument. It suggests that physicians may have a greater obligation to their current patients than to future patients who might benefit from new treatments. If this is true, then physicians may not be morally obligated to encourage their current patients to participate in clinical trials. Therefore, option E casts the most doubt on the conclusion of the argument
(B) Patients do not share the physician’s professional concern for public health, but everyone has a moral obligation to alleviate suffering when able to do so. This answer choice does not address the argument's claim that physicians have a moral obligation to encourage suitable patients to volunteer for clinical trials. Furthermore, it is not clear how this claim is relevant to the argument.
(C) Usually, half the patients in a clinical trial serve as a control group and receive a nonactive drug in place of the drug being tested. This answer choice does not cast doubt on the conclusion of the argument. It does not address the argument's claim that physicians have a moral obligation to encourage suitable patients to volunteer for clinical trials.
(D) An experimental drug cannot legally be made available to patients unless those patients are subjects in clinical trials of the drug. This answer choice does not cast doubt on the conclusion of the argument. It supports the argument's claim that clinical trials are necessary before drugs can be made available to patients, but it does not address the argument's claim that physicians have a moral obligation to encourage suitable patients to volunteer for clinical trials.
(E) Physicians have an overriding moral and legal duty to care for the health and safety of their current patients. This answer choice casts doubt on the conclusion of the argument. It suggests that physicians may have a greater obligation to their current patients than to future patients who might benefit from new treatments. If this is true, then physicians may not be morally obligated to encourage their current patients to participate in clinical trials. Therefore, option E casts the most doubt on the conclusion of the argument
07 Oct 2024, 21:29
Kudos
Bookmarks
Hi experts GMATNinja AjiteshArun KarishmaB
For
(D) An experimental drug cannot legally be made available to patients unless those patients are subjects in clinical trials of the drug.
why is this line of reasoning wrong?
I understand that we need to weaken that "practicing physicians are morally in the wrong when, in the absence of any treatment proven to be effective, they fail to encourage suitable patients to volunteer for clinical trials."
I thought that if these drugs are being tested out currently for future generations and together with the information provided in D, it means that the future generations themselves will have to be in the control group for the drug being tested which sounds illogical. I thought this took away the blame from the practicing physicians as they could not do anything in this case.
For
(D) An experimental drug cannot legally be made available to patients unless those patients are subjects in clinical trials of the drug.
why is this line of reasoning wrong?
I understand that we need to weaken that "practicing physicians are morally in the wrong when, in the absence of any treatment proven to be effective, they fail to encourage suitable patients to volunteer for clinical trials."
I thought that if these drugs are being tested out currently for future generations and together with the information provided in D, it means that the future generations themselves will have to be in the control group for the drug being tested which sounds illogical. I thought this took away the blame from the practicing physicians as they could not do anything in this case.
07 Oct 2024, 23:36
Kudos
Bookmarks
manrasingh
Hi manrasingh,
Let's look at it this way: we have (currently) experimental treatments. Some of these treatments may prove to not be safe and effective, but other experimental treatments may turn out to be safe and effective, at which point they would stop being experimental. At that point (in the future) the safe and effective treatments would benefit the lives and health of future generations. Keep in mind that all of this depends on testing the currently experimental treatments.
The author tells us that ~doctors should therefore encourage some of their patients (the ones who ~don't have any options left) to volunteer for clinical trials for these experimental treatments.
Now, let's take a look at option D: "An experimental drug cannot legally be made available to patients unless those patients are subjects in clinical trials of the drug."
If clinical trials are the only legal way to achieve what the author wants, then it becomes even more important for doctors to encourage their patients to sign up for these clinical trials.
